TrialLancet (London, England)2019

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.

RIGHT-2 InvestigatorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.